Physician profile
Tabitha Anne Casilli
NPI 1346568953
$820.50
in general payments reported to CMS, 2019-2025
13 companies · $359 in 2025
The $359 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.93 · 2023: $77.24 · 2024: $368 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $191.35 | 2024-2025 | |
| Medtronic, INC. | $148.83 | 2025 | Minimed 780g |
| Beta Bionics, INC. | $145.99 | 2024 | Ilet Bionic Pancreas |
| Sequel Med Tech, LLC | $130.03 | 2025 | Twiist |
| Amneal Pharmaceuticals LLC | $31.53 | 2025 | Unithroid |
| Sanofi Pasteur INC. | $31.22 | 2023 | |
| Sobi, INC | $23.36 | 2023 | |
| Verrica Pharmaceuticals INC. | $22.70 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $22.66 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Millicent US INC | $20.04 | 2024 | Intrarosa |
| Pfizer INC. | $19.74 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $17.12 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $15.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Casilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.